Lapatinib

Cell Line Origin Human Caucasian lung large cell carcinoma Cell Line Description The cell line COR-L23/R is a multi-drug resistant (MDR) sub-line derived from the parent line COR-L23 (Sigma Catalogue number. 92031919) after treatment with

Cell Line Origin Human lung small cell carcinoma Cell Line Description COR-L279 has been isolated from a lymph node of an untreated 63 year-old male. The degenerated and necrotic morphology of the sample obtained was consistent with metastatic

Cell Line Origin Human lung small cell carcinoma Cell Line Description COR-L311 has been isolated from a 63 year-old male patient with extensive disease and relapse after 3 cycles of chemotherapy treatment with eroposide, colchicine, methotrexate

Cell Line Origin Human Caucasian lung small cell carcinoma Cell Line Description Derived from the pleural effusion of a 55-year-old Caucasian male. Application Studies on lung cancer DNA Profile STR-PCR Data: Amelogenin: X CSF1PO: 10 D13S317: 11

Lapatinib is a tyrosine kinase inhibitor, targeting both the epidermal growth factor receptors, ErbB1 and ErbB-2. In combination with trastuzumab, it is reported to show complementary mechanisms of action and synergistic antitumor activity in

The Defender 3000 Bases provide economical yet durable performance for industrial weighing. With Legal-for-Trade certifications, these bases can be used for both general applications as well as where legal-for-trade performance is required.

PrEST Antigen ST13 suppression of tumorigenicity 13 (colon c

PrEST Antigen ST13 suppression of tumorigenicity 13 (colon c

PrEST Antigen ST13 suppression of tumorigenicity 13 (colon c

PrEST Antigen ST13 suppression of tumorigenicity 13 (colon c

Cell Line Origin Human squamous carcinoma of the tongue Cell Line Description 25 year old male. Growth is enhanced by use of a feeder layer of X-irradiated STO cells.